- Denmark’s central bank more than doubled its growth forecast for this year.
- The upgrade is driven by surging US sales and production at Novo Nordisk A/S, which fuel strong exports in Denmark’s pharmaceutical industry.
- The forecast ties Danish export strength directly to Novo Nordisk’s US business.
Quotes
“surging US sales and production at Novo Nordisk A/S fuel strong exports”